What is Photocure ASA?
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHCUF · Verdict
Solid reward · moderate risk
PHCUF scores well on volatility and balance sheet with no major weaknesses flagged in the model.
Based on 88% data coverage
PHCUF · Verdict
Top decile vs peers
Interest covered 3.3×
Model-based scoring. For information only — not financial advice.
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 196.83M, and a P/E ratio of 700.0x.
The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.